Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Guercio, B. J., Sarfaty, M., Teo, M. Y., Ratna, N., Duzgol, C., Funt, S. A., Lee, C.-H., Aggen, D. H., Regazzi, A. M., Chen, Z., Lattanzi, M., Al-Ahmadie, H. A., Brannon, A. R., Shah, R., Chu, C., Lenis, A. T., Pietzak, E., Bochner, B. H., Berger, M. F., … Iyer, G. (2023). Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience. Clinical Cancer Research, 29(22), 4586–4595. https://doi.org/10.1158/1078-0432.ccr-23-1283
Authors:
Brendan J Guercio
Michal Sarfaty
Min Yuen Teo
Neha Ratna
Cihan Duzgol
Samuel A Funt
Chung-Han Lee
David H Aggen
Ashley M Regazzi
Ziyu Chen
Michael Lattanzi
Hikmat A Al-Ahmadie
A Rose Brannon
Ronak Shah
Carissa Chu
Andrew T Lenis
Eugene Pietzak
Bernard H Bochner
Michael F Berger
David B Solit
Jonathan E Rosenberg
Dean F Bajorin
Gopa Iyer
Affiliated Authors:
Andrew T Lenis
Publication Type:
Article
Unique ID:
10.1158/1078-0432.ccr-23-1283
PMID:
Publication Date:
Data Source:
PubMed

Record Created: